Upgrade to SI Premium - Free Trial

Alnylam Pharmaceuticals (ALNY) PT Raised to $193 at Stifel Following Results

August 3, 2021 10:51 AM
Stifel analyst Paul Matteis raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $193.00 (from $178.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles